Table 2.
Effects of cisplatin (8 and 10 µM) and enoxaparin sodium (0.1, 0.5, 1, 5, 10, 50, and 100 µg/ml) on H357 cell viability (ANOVA test).
| Treatment/Time point | Absorbance (% over control) | p-value |
|---|---|---|
| mean ± SD* | ||
| Cisplatin 8 µM/24 h | <0.001 | |
| Cisplatin 8 µM | 82.26 ± 12.23 | |
| Cisplatin 8 µM + Enoxaparin sodium 0.1 µg/ml | 106.42 ± 3.59 | |
| Cisplatin 8 µM + Enoxaparin sodium 0.5 µg/ml | 99.48 ± 3.32 | |
| Cisplatin 8 µM + Enoxaparin sodium 1 µg/ml | 94.04 ± 4.54 | |
| Cisplatin 8 µM + Enoxaparin sodium 5 µg/ml | 94.37 ± 8.69 | |
| Cisplatin 8 µM + Enoxaparin sodium 10 µg/ml | 92.37 ± 3.57 | |
| Cisplatin 8 µM + Enoxaparin sodium 50 µg/ml | 88.61 ± 2.16 | |
| Cisplatin 8 µM + Enoxaparin sodium 100 µg/ml | 83.26 ± 10.92 | <0.001 |
| Cisplatin 8 µM/48 h | ||
| Cisplatin 8 µM | 103.69. ± 29.54 | |
| Cisplatin 8 µM + Enoxaparin sodium 0.1 µg/ml | 81.13 ± 8.39 | |
| Cisplatin 8 µM + Enoxaparin sodium 0.5 µg/ml | 89.60 ± 18.11 | |
| Cisplatin 8 µM + Enoxaparin sodium 1 µg/ml | 96.82 ± 14.07 | |
| Cisplatin 8 µM + Enoxaparin sodium 5 µg/ml | 87.29 ± 10.33 | |
| Cisplatin 8 µM + Enoxaparin sodium 10 µg/ml | 78.65 ± 13.95 | |
| Cisplatin 8 µM + Enoxaparin sodium 50 µg/ml | 77.07 ± 4.09 | |
| Cisplatin 8 µM + Enoxaparin sodium 100 µg/ml | 76.39 ± 10.78 | |
| Cisplatin 8 µM/72 h | <0.001 | |
| Cisplatin 8 µM | 107.13 ± 13.78 | |
| Cisplatin 8 µM + Enoxaparin sodium 0.1 µg/ml | 109.57 ± 13.82 | |
| Cisplatin 8 µM + Enoxaparin sodium 0.5 µg/ml | 102.78 ± 9.52 | |
| Cisplatin 8 µM + Enoxaparin sodium 1 µg/ml | 98.25 ± 10.45 | |
| Cisplatin 8 µM + Enoxaparin sodium 5 µg/ml | 95.54 ± 8.92 | |
| Cisplatin 8 µM + Enoxaparin sodium 10 µg/ml | 89.68 ± 5.71 | |
| Cisplatin 8 µM + Enoxaparin sodium 50 µg/ml | 89.08 ± 4.61 | |
| Cisplatin 8 µM + Enoxaparin sodium 100 µg/ml | 78.61 ± 8.62 | |
| Cisplatin 10 µM/24 h | <0.001 | |
| Cisplatin 10 µM | 80.33 ± 24.92 | |
| Cisplatin 10 µM + Enoxaparin sodium 0.1 µg/ml | 105.32 ± 11.96 | |
| Cisplatin 10 µM + Enoxaparin sodium 0.5 µg/ml | 93.59 ± 6.11 | |
| Cisplatin 10 µM + Enoxaparin sodium 1 µg/ml | 85.58 ± 7.36 | |
| Cisplatin 10 µM + Enoxaparin sodium 5 µg/ml | 86.88 ± 6.57 | |
| Cisplatin 10 µM + Enoxaparin sodium 10 µg/ml | 80.21 ± 6.81 | |
| Cisplatin 10 µM + Enoxaparin sodium 50 µg/ml | 80.58 ± 4.65 | |
| Cisplatin 10 µM + Enoxaparin sodium 100 µg/ml | 78.92 ± 4.41 | |
| Cisplatin 10 µM/48 h | 0.616 | |
| Cisplatin 10 µM | 97.12 ± 44.61 | |
| Cisplatin 10 µM + Enoxaparin sodium 0.1 µg/ml | 102.21 ± 23.52 | |
| Cisplatin 10 µM + Enoxaparin sodium 0.5 µg/ml | 93.97 ± 14.99 | |
| Cisplatin 10 µM + Enoxaparin sodium 1 µg/ml | 89.82 ± 14.93 | |
| Cisplatin 10 µM + Enoxaparin sodium 5 µg/ml | 87.65 ± 15.31 | |
| Cisplatin 10 µM + Enoxaparin sodium 10 µg/ml | 86.92 ± 14.91 | |
| Cisplatin 10 µM + Enoxaparin sodium 50 µg/ml | 85.71 ± 15.85 | |
| Cisplatin 8 µM + Enoxaparin sodium 100 µg/ml | 83.91 ± 10.98 | |
| Cisplatin 10 µM/72 h | <0.001 | |
| Cisplatin 10 µM | 92.61 ± 16.64 | |
| Cisplatin 10 µM + Enoxaparin sodium 0.1 µg/ml | 44.22 ± 28.11 | |
| Cisplatin 10 µM + Enoxaparin sodium 0.5 µg/ml | 43.71 ± 26.87 | |
| Cisplatin 10 µM + Enoxaparin sodium 1 µg/ml | 42.83 ± 24.83 | |
| Cisplatin 10 µM + Enoxaparin sodium 5 µg/ml | 39.31 ± 21.81 | |
| Cisplatin 10 µM + Enoxaparin sodium 10 µg/ml | 41.64 ± 26.09 | |
| Cisplatin 10 µM + Enoxaparin sodium 50 µg/ml | 36.36 ± 18.53 | |
| Cisplatin 10 µM + Enoxaparin sodium 100 µg/ml | 34.23 ± 14.57 |
*SD, standard deviation.